Shocked at Patanjali's 'blatant lie of WHO certification', says IMA

The launch was attended by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.

Coronil launch
Yoga guru Ramdev flanked by Union ministers Harsh Vardhan (left) and Nitin Gadkari at last week’s launch of Coronil PTI
Ruchika Chitravanshi New Delhi
3 min read Last Updated : Feb 22 2021 | 11:35 PM IST
The Indian Medical Association (IMA) has expressed shock at the “blatant lie of WHO certification” of Patanjali’s Coronil and questioned Health Minister Harsh Vardhan for promoting the drug.

In a strongly worded statement, the IMA asked Vardhan the ethics of such endorsement and release of “such falsely fabricated and unscientific product to the people of the whole country”.

Yoga guru Ramdev had on Friday released a paper by Haridwar-based Patanjali Research Institute on Coronil, which it claimed to be the “first evidence-based ayurvedic medicine” against the coronavirus disease.

“Coronil has received the Certificate of Pharmaceutical Product (CoPP) from the Ayush section of Central Drugs Standard Control Organisation as per the WHO certification scheme,” said Patanjali in a statement.

The launch was attended by Union Health Minister Harsh Vardhan and Transport Minister Nitin Gadkari.

Following this, World Health Organization South-East Asia said in a tweet: “@WHO has not reviewed or certified the effectiveness of any traditional medicine for the treatment #Covid19.” The company had issued a clarification, just ahead of the WHO’s tweet: “We want to clarify to avoid confusion that our WHO GMP compliant CoPP certificate to Coronil is issued by DCGI... It is clear that WHO does not approve or disapprove any drugs. WHO works for building a better, healthier future for people all over the world.”

IMA has sought details of the timeline of clinical trials of the Coronil drug from the health minister. “Can you clarify the number of patients in the double blind or single blind trials of this so-called anti-corona product promoted by you? On what ground was it approved by the DCGI as was announced in your presence?” the IMA statement reads.

Referring to Ramdev’s statement that modern medicine was medical terrorism, IMA said in reply: “Being the health minister of the country and a modern medicine doctor, can you clarify the highly objectionable and instigative statement by Ramdev.”

IMA also said: “The country needs an explanation from the minister. The Indian Medical Association will also write to the National Medical Commission for seeking suo moto explanation for his blatant disrespect to the code of conduct of Medical Council of India.”

Quoting the code of conduct under the Indian Medical Council Act, the IMA statement said no doctor can promote any drug, for compensation or otherwise. “Dispensing by a physician of a secret remedial agents of which he does not know the composition, or the manufacture or promotion of their use is unethical and as such prohibited.”

Ramdev-led Patanjali Ayurved had launched Coronil on June 23. Patanjali CEO Acharya Balkrishna claimed that the medicine could cure Covid-19 patients within 5-14 days.

At the time of the launch of the drug, the AYUSH ministry had asked the company to stop ads for the drug until the issue had been examined. The ministry had also sought a detailed report on composition, testing and other data for the drug. The Centre had barred the firm from advertising the products after Ramdev said they cured 280 patients within days in trials. Coronil was then passed as an “immuno-booster” only.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirusindian medical associationPatanjaliWHOHealth Ministry

Next Story